Target intelligence / Profile preview

Soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex (SNARE complex) (SNARE complex)

Target
SNARE complex
Molecular classification
Protein complex, Membrane-associated proteins
01

Overview

The presynaptic cholinergic nerve terminal SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) exocytosis machinery is a specialized protein complex responsible for the release of acetylcholine into the neuromuscular junction and autonomic synapses (Jahn & Scheller, 2006). It primarily consists of three key proteins: synaptobrevin (also known as vesicle-associated membrane protein or VAMP) on the vesicle membrane, and syntaxin-1 and SNAP-25 on the presynaptic plasma membrane (Rossetto et al., 2014). These proteins assemble into a stable four-helix bundle that pulls the vesicle and plasma membranes into close proximity, facilitating membrane fusion and subsequent neurotransmitter exocytosis. This machinery is the primary target for botulinum neurotoxins (BoNTs), which act as highly specific zinc-dependent endopeptidases (Dressler et al., 2005). By cleaving specific components of the SNARE complex—such as SNAP-25 by BoNT/A or synaptobrevin by BoNT/B—these toxins prevent the formation of the fusion complex, effectively blocking cholinergic transmission (Dhaked et al., 2010). This mechanism is therapeutically exploited to treat conditions characterized by muscle overactivity, such as cervical dystonia, spasticity, and chronic migraine, as well as for cosmetic applications.

Other names
Synaptic fusion complexVAMP/Syntaxin/SNAP-25 complexExocytosis machineryPresynaptic SNARE complex
02

Mechanism of action

Proteolytic cleavage of SNARE proteins (SNAP-25, Syntaxin, or VAMP), preventing the formation of the SNARE complex and inhibiting acetylcholine release.

03

Biological functions

Neurotransmitter releaseVesicle fusionExocytosisSynaptic transmission
04

Disease associations

Muscle spasticityDystoniaChronic migraineHyperhidrosisSialorrheaStrabismusBlepharospasm
05

Safety considerations

Distant spread of toxin effectMuscle weaknessDysphagiaRespiratory failureImmunogenicity
06

Interacting drugs

OnabotulinumtoxinA

6 more in the full profile.

07

Biomarkers

Compound muscle action potential (CMAP)Clinical improvement in muscle toneAcetylcholine levels

Beyond the preview

Go deeper on Soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex (SNARE complex) (SNARE complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex (SNARE complex) (SNARE complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call